Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Scilex Holding Company stock logo
SCLX
Scilex
$1.25
-12.6%
$3.32
$1.24
▼
$27.00
$13.25M1.8539,506 shs90,572 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Scilex Holding Company stock logo
SCLX
Scilex
0.00%-15.88%-49.47%-77.66%-91.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Scilex Holding Company stock logo
SCLX
Scilex
$1.25
-12.6%
$3.32
$1.24
▼
$27.00
$13.25M1.8539,506 shs90,572 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Scilex Holding Company stock logo
SCLX
Scilex
0.00%-15.88%-49.47%-77.66%-91.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Scilex Holding Company stock logo
SCLX
Scilex
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest SCLX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/18/2026
Scilex Holding Company stock logo
SCLX
Scilex
DowngradeSell (D-) ➝ Sell (E+)
9/2/2026
Scilex Holding Company stock logo
SCLX
Scilex
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Scilex Holding Company stock logo
SCLX
Scilex
$31.61M0.34N/AN/A($24.94) per share-0.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Scilex Holding Company stock logo
SCLX
Scilex
-$358.73M-$49.70N/AN/AN/A-1,414.57%N/A-147.00%12/2/2026 (Estimated)

Latest SCLX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
12/2/2026Q3 2026
Scilex Holding Company stock logo
SCLX
Scilex
-$0.0756N/AN/AN/A$17.00 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Scilex Holding Company stock logo
SCLX
Scilex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Scilex Holding Company stock logo
SCLX
Scilex
N/A
0.07
0.06

Institutional Ownership

CompanyInstitutional Ownership
Scilex Holding Company stock logo
SCLX
Scilex
69.67%

Insider Ownership

CompanyInsider Ownership
Scilex Holding Company stock logo
SCLX
Scilex
4.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Scilex Holding Company stock logo
SCLX
Scilex
348.49 million8.11 millionNo Data

Recent News About These Companies

Scilex (NASDAQ:SCLX) Stock Price Down 8.3% - Here's Why
Scilex Holding Company (NASDAQ: SCLX) - Share Price and Research
Scilex Holding Company

New MarketBeat Followers Over Time

Media Sentiment Over Time

Scilex stock logo

Scilex NASDAQ:SCLX

$1.25 -0.18 (-12.59%)
Closing price 04:00 PM Eastern
Extended Trading
$1.25 +0.00 (+0.40%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California.